Results
1
High Growth Stocks
1 companies
Kuros Biosciences
Market Cap: CHF 868.8m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 21.90
7D
-5.0%
1Y
-18.8%
